Quantitative Cross-linking Lens

UV Delivery + Biomechanical Monitoring

CXLens® is applied to the scleral surface of the eye (vaulting over the cornea) following administration of Vitamin B2 (Riboflavin) eye drops. CXLens  emits patterned Ultraviolet (UV) light to crosslink specific areas of the cornea CXLens UV illumination continues until an on-board sensor and algorithms determine that certain biomechanical properties of the corneal stroma have been adjusted to pre-planned values.. This  closed loop dosing allows for , precise control over corneal shape and this should be able to predictably improve a patient’s vision.

TECLens System

Comfortable, Precise, Personalized Treatment

The scleral design of CXLens is very comfortable for the patient and stable on the eye. Patients can be treated with eyes opened or closed, sitting upright in a chair or lying down. The contact lens form factor is familiar to contact lens wearers, helping to eliminate the fear associated with laser correction procedures.

qCXL(TM) for Accurate Refractions

CXLens is unique in the corneal cross-linking field enabling Quantitative Cross-linking (qCXL). Sitting directly on the eye, it’s built-in Ultrasound transducer provides real-time elastography feedback during cross-linking helping to enabling precise, customized closed loop dosing (selective stiffening of the corneal surface) required for predictable refractive outcomes.

CXLens cross-section

US Transduer

CXLens Ultrasound Transducer

Ultrasound is transmitted through the UV beam (not possible with off-eye crosslinking systems) to measure real-time biomechanical parameters.

TECLens / SERVImed Proprietary Trans-Epithelial Riboflavin

Simplicity and Scale

TECLens System

TECLens provides a technologically advanced cross-linking platform without sacrificing operational simplicity and affordability.


For Patients

For Physicians

Target Indications


Corneal Ectasia following refractive surgery

Pediatric Progressive Myopia

Low Myopia



Refractive Tune-up after IOL placement

US Patents 9,883,970  | 9,861,526  |  9,907,698 |  10,010,449 | 10,548,772 | 10,548,773 (and corresponding OUS Patents), and several Patents Pending. TECLens® & CXLens® are Registered Trademarks of TECLens, Inc.

Quantitative Corneal Cross-linking” , “Quantitative Cross-linking” & “qCXL” ©2020 TECLens, Inc. All rights reserved.